Top Philadelphia, PA Biotech Companies (56)

Context Therapeutics is a clinical-stage biopharmaceutical company.

Penn Biotech Group (PBG) is a cross-disciplinary student run organization at the University of Pennsylvania.

Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.

We are a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering high-quality medicines for people living with rare metabolic diseases. Amicus is the Latin word for friend. This name signifies our collaborative approach to developing medicines by incorporating the patient perspective every step of the way. Our company was founded by an entrepreneur who embarked on a life-long...

National Disease Research Interchange is the source of human tissues, cells and organs for scientific research.

FMC Corporation is an US-based chemical manufacturing company producing solutions for the agricultural, textile, and healthcare industries. FMC Corporation is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment. FMC’s innovative crop protection solutions – including biologicals, crop nutrition, digital and precision agriculture –...

BioDetego is developing, VASPfore, a new biomarker test for selecting cancer treatment protocols.

Unlocking the Potential of Genetic Medicines Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins. The company is developing a wholly-owned pipeline of Centyrin-based therapeutic candidates and is working with industry partners to leverage Centyrins for tissue-specific targeting of therapeutics for a diverse...

Talee Bio is to change the course of cystic fibrosis and other genetic lung diseases.

Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.

Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.

Amyndas is a pharmaceutical company

Jazz Pharmaceuticals plc (Nasdaq: JAZZ), is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are focused on developing life-changing medicines for people with serious diseases—often with limited or no options—so they can live their lives more fully. By transforming biopharmaceutical discoveries into novel medicines, we are working to give...

Avid Radiopharmaceuticals develops molecular imaging agents for detecting and monitoring chronic human diseases.

Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies

We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics. Deeply rooted in science and innovation, our vision is to compassionately contribute to solving cancer.

Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.

NexusPharma is dedicated to the discovery of novel therapeutics.

CoJourney CO. is reimagining cell and gene therapy CDMO services globally. Our platform is built on High Purity, High Yield, On Time Supply and Significantly Reduced Costs. We provide process development and clinical and commercial mfg. through a range of platform technologies, including: (1) Plasmids, (2) mRNA, (3) AAV / adenovirus, (4) Lentivirus, (5) Retrovirus, (6) Custom Viral Vectors. We...

Verismo Therapeutics is pioneering the development of novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer, especially non-hematologic malignancies with few effective therapeutic options. Verismo Therapeutic’s core technology is built upon CARs that are uniquely engineered to more realistically reflect the natural multichain design of killer immunoglobulin-like receptors (KIRs), an important family of immunologic receptors used by...